Alvotech ALVO 深 滬
等待開盤 02-06 09:30:00 美东时间
4.99
-0.100
-1.96%
華盛通- 最 高5.285
- 今 開5.15
- 成交量 39.04万股
- 最 低 4.95
- 昨 收 5.09
- 總市值 15.62亿
- 52周最高 12.89
- 市盈率 靜 --
- 換手率 0.12%
- 52周最低 4.32
- 委 比 98.90%
- 總股本 3.13亿
- 歷史最高 18.00
- 量 比 1.07
- 振 幅 6.58%
- 歷史最低 4.32
- 每 手 1
- 風險率 2.24%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Alvotech higher on positive data backing biosimilar to Takeda’s Entyvio
Alvotech (ALVO) shares spiked ~3% in the premarket on Thursday after the Luxembourg-based biotech succeeded in a study designed to evaluate AVT80, its proposed biosimilar to Entyvio, a bowel disease t...
02-05 21:15
Alvotech's AVT80 Biosimilar To Entyvio Passes Key Pharmacokinetic Study, Showing Safety And Immunogenicity Profiles In Healthy Participant
The study, which assessed the pharmacokinetics, safety, tolerability and immunogenicity of AVT80 compared to Entyvio® in healthy adult participants, met all its primary endpoints
02-05 16:24
Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg
Alvotech has resolved all global patent disputes related to its Eylea® biosimilar, AVT06, through a licensing and settlement agreement with Regeneron and Bayer. This allows Alvotech and its partners to market AVT06 in the UK, Canada, Japan, and other countries starting January 1, 2026, with U.S. entry pending regulatory approval in Q4 2026. AVT06 is approved under the names Mynzepli®, Afiveg®, and Aflibercept BS. Regional partners include Advanz ...
01-29 08:00
Alvotech Reports Major Insider-Related Share Purchases Filed in Luxembourg
Alvotech ( ($ALVO) ) has provided an announcement. On January 6, 2026, Alvotech...
01-08 00:27
Correction: Transactions of Managers and Closely Associated Persons
Copies of two filings with the Luxembourg CSSF regarding ATP Holdings' transactions were attached. ATP Holdings acquired 4,812,257 Alvotech shares on December 17, 2025, and sold 2,110,640 shares on December 19, 2025, at SEK 44.06 per share. The initial announcement mistakenly labeled the December 19 transaction as an acquisition.
01-07 22:00
Why Bolt Projects Holdings Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
Shares of Bolt Projects Holdings Inc (NASDAQ:BSLK) rose sharply in pre-market t...
2025-12-29 17:58
美股大行评级 | 花旗上调苹果目标价升至330美元；GPCR、KYMR、MAMA、TERN、WVE等获多家机构上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从12美元升至13美元；Guggenheim：维持Praxis Precision Medicine"买入"评级，目标价从540美元升至760美元
2025-12-10 10:33
Barclays Initiates Coverage On Alvotech with Underweight Rating, Announces Price Target of $5
Barclays analyst Glen Santangelo initiates coverage on Alvotech (NASDAQ:ALVO) with a Underweight rating and announces Price Target of $5.
2025-12-09 23:16
Alvotech Wins EU Green Light For Cancer-Related Bone Treatment Alternative
Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Commission (EC) has approved AVT03 as a
2025-11-24 18:31
美股大行评级 | Stifel上调英伟达目标价升至250美元；大摩上调哔哩哔哩目标价升至27美元；NICE遭多家机构下调目标价
今日重点评级关注：Oppenheimer：维持Olema Pharmaceuticals"跑赢大市"评级，目标价从22美元升至45美元；Bernstein：维持Atlassian"跑赢大市"评级，目标价从290美元升至304美元
2025-11-19 11:01
